ScholarWorks@Korea University: Song, Gwan Gyu

Detailed Information

Song, Gwan Gyu (송관규)

College of Medicine (Department of Medical Science)

Research Area

Tel 구3065
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Metaanalysis:76||Polymorphism:67||Rheumatoid arthritis:30||metaanalysis:29||polymorphism:25||s disease:15||Pathwaybased analysis:12||Systemic lupus erythematosus:12||rheumatoid arthritis:11||Genomewide association study:11||Angiotensinconverting enzyme:6||Protein tyrosine phosphatase nonreceptor 22:6||systemic lupus erythematosus:5||Vitamin D receptor:5||Ankylosing spondylitis:5||Asthma:5||Psoriasis:5||Cytotoxic T lymphocyte antigen4:5||Osteoarthritis:5||Behcet&apos:5||Interleukin10:4||Microarray:4||Alzheimer&apos:4||Efficacy:4||Parkinson&apos:4||TNFalpha:4||Fibromyalgia:4||MTHFR:3||disease activity:3||Polymorphisms:3||Macrophages:3||FAS:3||CTLA4:3||Periodontitis:3||Bone mineral density:3||Interleukin23R:3||pathwaybased analysis:3||Vasculitis:3||COMT:3||Autoimmune diseases:3||Safety:3||lupus nephritis:3||CCR5Delta 32 polymorphism:3||treatment:2||RHEUMATOID ARTHRITIS:2||Type 1 diabetes:2||CD226:2||Rheumatoid:2||SYSTEMICLUPUSERYTHEMATOSUS:2||cardiovascular disease:2||BMD:2||smoking:2||Diagnostic accuracy:2||responsiveness:2||spondyloarthropathy:2||mortality:2||genomewide association study:2||p53:2||ERAP1:2||Multiple sclerosis:2||Interleukin18:2||PPAR gamma:2||Tolllike receptor:2||multiple sclerosis:2||Synovial macrophages:2||psoriasis:2||Amyotrophic lateral sclerosis:2||AUTOIMMUNEDISEASES:2||Bioinformatics:2||ADHD:2||Osteoporosis:2||vitamin D receptor:2||VEGF:2||Juvenile idiopathic arthritis:2||Systemic sclerosis:2||hepatitis B virus reactivation:2||FCRL3:2||ADAM33:2||INFLAMMATION:2||POPULATION:2||MicroRNA:2||Tumor necrosis factor:2||Arthritis:2||Gout:2||Gene expression:2||TREM1:2||SUSCEPTIBILITY LOCI:2||RHEUMATOIDARTHRITIS:2||RISK:2||Takayasu arteritis:2||Intraarticular injection:1||MPV:1||epidemiology:1||FCGR3B:1||Copy number variation:1||vitiligo:1||Paraoxonase:1||MTX toxicity:1||Nonresponsiveness:1||Tofacitinib:1||Response:1||rheumatic diseases:1||IVC thrombosis:1||Vitiligo:1||Prostaglandin D2 receptor:1||vasculitis:1||Endothelial nitric oxide synthase:1||EVEROLIMUS:1||SYSTEM:1||ETIOLOGY:1||LATVIAN PATIENTS:1||VARIANT:1||Phox homology domain containing serine/threonine kinase:1||Omega3 polyunsaturated fatty acids:1||Mannosebinding lectin:1||cyclophosphamide:1||1:1||25(OH)2D3:1||Mast cell:1||COLLAGEN:1||genetic polymorphism:1||INTERLEUKIN 1:1||GENETIC POLYMORPHISM:1||corticosteroid:1||TNF inhibitors:1||cluster analysis:1||SLEDAI:1||dmards (synthetic):1||Antiinflammation:1||crosssectional:1||gout:1||Mendelian randomization:1||uric acid level:1||Golimumab:1||Korean Health Assessment Questionnaire:1||US:1||DECT:1||Pulmonary sarcoidosis:1||Imaging:1||Etoricoxib:1||Celecoxib:1||Naproxen:1||sarcoidosis:1||biologic agent:1||tuberculin skin test:1||ICAM1:1||Tea:1||Disease susceptibility:1||Mannosebinding lectin gene:1||Promoter regions, genetic:1||Breast cancer:1||antiCCP antibodies:1||Extension Study:1||antitumor necrosis factor therapy:1||Monocytes:1||Interferon regulatory factor 5:1||hepatitis B virus occult carrier:1||systemic sclerosis:1||Susceptibility:1||RAPAMYCIN:1||HUMAN OX40 LIGAND:1||SUPERFAMILY:1||COMPLEMENT:1||MOLECULAR NETWORKS:1||NEPHRITIS:1||TOOL:1||cohort study:1||Rituximab:1||IL1 beta:1||STAT4:1||Chondroitin:1||Knee:1||Rat:1||IL3:1||SYNOVIALFLUID:1||BONE LOSS:1||S DISEASE:1||NLR:1||Disease Activity Score:1||FCGR polymorphism:1||SLE:1||melanoma:1||RA:1||Complement system proteins:1||PAL1:1||Sarcoidosis:1||MICA:1||PlaceboControlled Clinical Trial:1||DMARD:1||Schizophrenia:1||IL18:1||ovarian cancer:1||Activity:1||MAMMALIAN TARGET:1||ANALOGS:1||GENOMEWIDE ASSOCIATION:1||IDENTIFICATION:1||GENE POLYMORPHISMS:1||GENE:1||Migration inhibitory factor:1||interleukin6:1||erythematosus:1||MCP1:1||F18 FDG PET:1||Fibrosis:1||MECHANISMS:1||Fc receptors:1||bone mineral density:1||Gut microbiome:1||organ damage:1||5HTTLPR:1||EuroQol EQ5D:1||patientreported outcomes:1||Venous thromboembolism:1||Adalimumab:1||Paradoxical response:1||RPL:1||type 1 diabetes:1||schizophrenia:1||abdominal aortic aneurysm:1||QuantiFERONTB Gold InTube test:1||susceptibility:1||ulcerative colitis:1||TNFalpha polymorphism:1||breast cancer:1||Major depressive disorder:1||MMP:1||TLR:1||antitumour necrosis factor therapy:1||MONOCYTES:1||PATHWAY:1||preeclampsia:1||Interleukin23 R:1||GSTM1:1||Rheumatic diseases:1||SURVIVAL:1||Genomewide association studies:1||TCELLS:1||GENES:1||LOCI:1||GLU298ASP:1||REGION:1||RESPONSES:1||TNF:1||Thalidomide:1||Lung:1||Stem cell factor:1||Bone marrow:1||PENTOSIDINE:1||polymorphisms:1||METAANALYSIS:1||SINGLENUCLEOTIDE POLYMORPHISMS:1||Diacerein:1||coffee:1||relationship:1||ankylosing:1||Prolactin level:1||Recurrent pregnancy loss:1||F13AI Val34Leu:1||Polymyositis:1||Etanercept:1||Tumor necrosis factoralpha:1||antiinflammatory activity:1||Specificity:1||Duloxetine:1||Pregabalin:1||pancreatic cancer:1||Pathway analysis:1||Mucocutaneous lymph node syndrome:1||FCGR3A:1||Variant alleles:1||Attentiondeficit/hyperactivity disorder:1||shared epitope:1||TRAF1C5:1||Infliximab:1||Adverse Event:1||FCGR:1||Protein S activity:1||MACROPHAGES:1||NITRICOXIDE SYNTHASE:1||AUTOIMMUNE:1||DISEASES:1||Tyrosine kinase 2:1||JAPANESE POPULATION:1||Interleukin6:1||beta(2)glycoprotein I:1||prospective study:1||Ibandronic acid:1||mycophenolate mofetil:1||Glucosamine:1||Structural efficacy:1||genetic risk score:1||Fc gamma RECEPTOR:1||Korea:1||PLR:1||quality of life:1||restenosis:1||Uveitis:1||항인지질항체 증후군:1||Diabetic nephropathy:1||Prolactin:1||latent tuberculosis infection:1||Coffee:1||Autoimmunity:1||Biologic agent:1||PCOS:1||Systematic review:1||IL6:1||PTPN22:1||Candidate gene:1||GSTP1:1||Vitamin D:1||ITGAM:1||SNPS:1||Metaanalysis:1||Antiphospholipid syndrome:1||Systemic lupus:1||systematic review:1||Bleomycin:1||Neuroblastoma:1||psoriatic arthritis:1||Spondylitis:1||Dermatomyositis:1||balloon angioplasty:1||complication:1||TANKbinding kinase 1:1||갑상선암:1||TNF blockers:1||Cancer:1||CCR5:1||GSTs:1||HLAG:1||Apolipoprotein E:1||Crohn&apos:1||TNFR:1||Biologics:1||GWAS:1||CYTOKINES:1||monocyte chemoattractant protein1:1||ENVIRONMENT:1||ARTERY:1||TRANSCRIPTION FACTORS:1||HETEROGENEITY:1||GOUT:1||SLC2A9:1||Inflammation:1||Review:1||CT:1||Paget&apos:1||TGFbeta:1||CYP24:1||DISEASE:1||LRP5:1||PDCD1:1||POLYMORPHISM:1||Poly(D,Llactidecoglycolide):1||Sustained drug delivery:1||uric acid:1||BDNF:1||Disease progression:1||stent implantation:1||ginsenoside Rc:1||p38:1||Panax ginseng:1||Giant cell arteritis:1||Sensitivity:1||Milnacipran:1||interferongamma release assay:1||TNFalpha inhibitors:1||Preeclampsia:1||Genetic polymorphisms:1||Publication bias:1||IL6 polymorphisms:1||Asporin:1||brainderived neurotrophic factor:1||LTalpha:1||BD:1||T1D:1||Association:1||Endometriosis:1||angiotensinconverting enzyme:1||1,25Dihydroxyviamin D3:1||interleukin4:1||interleukin12B:1||OSTEOCLASTS:1||CELLS:1||EXPRESSION:1||RECEPTORS:1||FAMILIES:1||A20:1||Associated vasculitis:1||tacrolimus:1||1,25Dihydroxyvitamin D3:1||ERK1/2:1||Osteoprotegerin:1||FC gamma RECEPTOR:1||adjusted indirect comparison:1||Mendelian randomization analysis:1||ADULT ONSET STILL&apos:1||

STATISTICS: Total View :6,091,859; Today View :3,994

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE